Cambridge, UK, – Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the leading international gene editing company supplying tools and services that power genomics research and the development of personalized medicines announces the launch of HDx FFPE RNA Fusion Reference Standards, independent analytical controls for the optimization and validation of targeted RNA-seq, endpoint […]
Austin, TX, Bioo Scientific announced that the United States Patent and Trademark Office (USPTO) has issued U.S. patent US9255291 entitled Oligonucleotide ligation, barcoding and methods and compositions for improving data quality and throughput using massively parallel sequencing. The granted claims describe a method for improving small RNA NGS library prep by reducing bias, formation of […]
PLEASANTON, Calif. – 10x Genomics, a company focused on improving and broadening the application of genomic information announced the close of a $55 million Series C financing. The financing round was led by Fidelity Management & Research Company and included additional new investors Softbank and JS Capital Management LLC, alongside founding investors Venrock, Foresite Capital, […]
SHENZHEN; SHANGHAI; CAMBRIDGE, Massachusetts; and REYKJAVIK, – Huawei, a leading global information and communications technology provider, and WuXi AppTec, the global open-access R&D platform, have announced the signing of a strategic framework agreement to support the China Precision Medicine Initiative (China PMI) through the creation of a state-of the-art precision medicine cloud platform. The agreement […]
CASTLE ROCK, Colo. — Venaxis®, Inc. (Nasdaq: APPY), announced today that Venaxis, Strand Life Sciences Private Limited (Strand LS) and its U.S. subsidiary Strand Genomics Inc. (SGI), have agreed to terminate the previously announced transactions between the companies. On March 11, 2016, Venaxis, Strand LS and SGI entered into a Mutual Termination Agreement to terminate […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) introduced OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data. Agilent unveiled its new bioinformatics product at the annual meeting of the American College of Medical Genetics and Genomics this week in Tampa, Florida. “The study […]
Ann Arbor, Michigan and Göteborg, Sweden – Swift Biosciences, a U.S-based company specializing in sample preparation for next generation sequencing (NGS), announces their partnership with TATAA Biocenter, the world´s foremost organizer of hands-on training in molecular diagnostics and Europe´s leading provider of genomic services. This strategic partnership will expand both Swift’s and TATAA’s presence in […]
Aliso Viejo, CA – Ambry Genetics, a leader in clinical genetic diagnostics and genetics software solutions, took a radical step to fulfill the promise of unlocking the human genome by launching AmbryShare (www.AmbryShare.com), the largest free, disease-specific public database of human genome sequencing data. This action is a conservative first step to support the global […]
Oakland – Omicia Inc. will launch its new ACMG-scoring module for the Opal Clinical™ interpretation and reporting software platform at the ACMG Annual Clinical Genetics Meeting in Tampa,March 8-12th. This functionality provides an intuitive interface and workflow for clinical testing labs to systematically assess the disease-causing potential of genetic variants using the evidence-based classification system […]
Milford, Massachusetts, – SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers, announced the launch of two new circulating tumor DNA (ctDNA) products at the 2016 Molecular Medicine Tri-Conference in San Francisco. The SeraseqTM Circulating Tumor DNA-I Reference Material and the SeraseqTM Circulating Tumor DNA-I Mutation Mix Kit are designed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
